SBRT, Chemotherapy, and AK112 Neoadjuvant Therapy for Luminal-type Breast Cancer
Clinical trial NCT06402435 · RECRUITING
Trial details
- NCT number
- NCT06402435
- Sponsor
- Hubei Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-28
- Primary completion
- 2026-08-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.